Access to weight reduction interventions for overweight and obese patients in UK primary care: Population-based cohort study

BMJ Open

Volumn 5, Issue 1, 2015, Pages

  Booth, Helen P ^a   Prevost, A Toby ^a   Gulliford, Martin C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT;

ADULT; AGED; ARTHROPATHY; ARTICLE; ASTHMA; BACKACHE; BODY MASS; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; DEPRESSION; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; GALLBLADDER DISEASE; HEALTH CARE ACCESS; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRESCRIPTION; SLEEP DISORDERED BREATHING; SMOKING; WEIGHT CONTROL; WEIGHT REDUCTION; COUNSELING; EXERCISE; HEALTH CARE DELIVERY; LIFESTYLE; MIDDLE AGED; OVERWEIGHT; PRIMARY HEALTH CARE; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-OBESITY AGENTS; BODY MASS INDEX; COHORT STUDIES; COUNSELING; ELECTRONIC HEALTH RECORDS; EXERCISE; FEMALE; GREAT BRITAIN; HEALTH SERVICES ACCESSIBILITY; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION;

EID: 84921345262     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006642     Document Type: Article

References (22)

1. Lopez AD, Mathers CD, Ezzati M, eds. Global burden of disease and risk factors. Washington: The World Bank & Oxford University Press, 2006.
2. Moody A. Chapter 10: adult anthropometric measures, overweight and obesity. London, UK: Health and Social Care Information Centre, 2013.
3. National Institute for Health and Care Excellence. Obesity: identification, assessment and management of overweight and obesity in children, young people and adults (draft for consultation). London, UK: National Institute for Health and Care Excellence, 2014; Contract No: CG43.
4. Ara R, Blake L, Gray L, et al. What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review. Health Technol Assess 2012;16: iii-xiv, 1-195. http://dx.doi.org/10.3310/hta16050
5. Avenell A, Broom J, Brown TJ, et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 2004;8:iii-iv, 1-182.
6. Picot J, Jones J, Colquitt J, et al. Weight loss surgery for mild to moderate obesity: a systematic review and economic evaluation. Obes Surg 2012;22:1496-506.
7. Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 2009;13:215-357.
8. Booth HP, Prevost AT, Wright AJ, et al. Effectiveness of behavioral weight loss interventions delivered in a primary care setting: a systematic review and meta-analysis. Fam Pract 2014;31:643-53.
9. Counterweight Project Team. Current approaches to obesity management in UK primary care: the Counterweight programme. J Hum Nutr Diet 2004;17:7.
10. Department of Health. Healthy lives, healthy people: a call to action on obesity. London: HM Government, 2011; Contract No: 16166.
11. Williams T, van Staa T, Puri S, et al. Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource. Ther Adv Drug Saf 2012;3:89-99.
12. Medicines and Healthcare Products Regulatory Agency. Suspension of sibutramine (Reductil). 2010 (19 March 2014). http://www.mhra.gov.uk/NewsCentre/CON068470
13. Medicines and Healthcare Products Regulatory Agency. Rimonabant: European suspension of marketing authorisation. 2008 (cited 26 August 2014). http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON087927
14. Kang JG, Park C-Y. Anti-obesity drugs: a review about their effects and safety. Diabetes Metab J 2012;36:13-25.
15. Cleves M, StataCorp. Analysis of multiple failure-time data with Stata. 2009 (cited 10 September 2014). http://www.stata.com/support/faqs/statistics/multiple-failure-time-data/
16. Srishanmuganathan J, Patel H, Car J, et al. National trends in the use and costs of anti-obesity medications in England 1998-2005. J Public Health (Oxf) 2007;29:199-202.
17. Yates EA, Macpherson AK, Kuk JL. Secular trends in the diagnosis and treatment of obesity among US adults in the primary care setting. Obesity 2012;20:1909-14.
18. McAlpine DD, Wilson AR. Trends in obesity-related counseling in primary care: 1995-2004. Med Care 2007;45:322-9.
19. Tsai AG, Wadden TA. Treatment of obesity in primary care practice in the United States: a systematic review. J Gen Intern Med 2009;24:1073-9.
20. LeBlanc ES, O'Connor E, Whitlock EP, et al. Effectiveness of primary care-relevant treatments for obesity in adults: s systematic evidence review for the U.S. Preventive services task force. Ann Intern Med 2011;155:434-47.
21. Jebb SA, Ahern AL, Olson AD, et al. Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. Lancet 2011;378:1485-92.
22. Dixon KJ, Shcherba S, Kipping RR. Weight loss from three commercial providers of NHS primary care slimming on referral in North Somerset: service evaluation. J Public Health (Oxf) 2012;34:555-61.